| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 13 | |
| #2 | Australia | 3 | |
| #3 | EPO (European Patent Office) | 3 | |
| #4 | WIPO (World Intellectual Property Organization) | 3 | |
| #5 | Israel | 1 | |
| #6 | Republic of Korea | 1 |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Peptides | |
| #3 | Therapeutic chemical compounds | |
| #4 | Polysaccharides | |
| #5 | Microorganisms | |
| #6 | Enzymes | |
| #7 | Sugars | |
| #8 | Nanostructure applications | |
| #9 | Climate change adaptation technologies | |
| #10 | Separation |
| # | Name | Total Patents |
|---|---|---|
| #1 | Jain Sanjay | 12 |
| #2 | Gregoriadis Gregory | 8 |
| #3 | Genkin Dmitry | 8 |
| #4 | Laing Peter | 6 |
| #5 | Papaioannou Ioannis | 6 |
| #6 | Surkov Kirill | 3 |
| #7 | Smirnov Ivan | 3 |
| #8 | Zhang Rongsheng | 3 |
| #9 | Bacon Andrew | 3 |
| #10 | Ponomarenko Natalia | 3 |
| Publication | Filing date | Title |
|---|---|---|
| WO2020099513A1 | Glycopolysialylation of blinatumomab | |
| WO2018197545A1 | Methods of treating multiple myeloma cancers expressing high levels of epo-receptor using psa-epo | |
| US2019083636A1 | Methods of treating diseases related to net formation with parenteral administration of polysialylated dnase i | |
| AU2015341700A1 | Method for treatment of primary hormone resistant endometrial and breast cancers | |
| AU2013246870A1 | Liposomes containing oligopeptide fragments of myelin basic protein, a pharmaceutical composition and a method for treatment of multiple sclerosis |